| 持有 上海莱士(002252)的基金 |
| 报告期：2024-09-30 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 161726 | 招商国证生物医药指数分级 | 663,139,509.00 | 83,941,710.00 | 6.00 |
| 2 | 512010 | 易方达沪深300医药ETF | 655,913,576.50 | 83,027,035.00 | 3.04 |
| 3 | 001186 | 富国文体健康股票 | 250,543,823.20 | 31,714,408.00 | 8.99 |
| 4 | 512290 | 国泰中证生物医药ETF | 210,855,558.30 | 26,690,577.00 | 5.04 |
| 5 | 501009 | 汇添富中证生物科技指数(LOF)A | 124,961,749.70 | 15,817,943.00 | 4.54 |
| 6 | 501010 | 汇添富中证生物科技指数(LOF)C | 124,961,749.70 | 15,817,943.00 | 4.54 |
| 7 | 159938 | 广发中证全指医药卫生ETF | 90,611,025.00 | 11,469,750.00 | 1.74 |
| 8 | 750001 | 安信灵活配置混合 | 83,863,240.00 | 10,615,600.00 | 6.13 |
| 9 | 159929 | 汇添富中证医药卫生ETF | 44,125,465.80 | 5,585,502.00 | 2.02 |
| 10 | 000780 | 鹏华医疗保健股票 | 14,831,460.00 | 1,877,400.00 | 2.82 |
| 11 | 000854 | 鹏华养老产业股票 | 13,677,270.00 | 1,731,300.00 | 2.89 |
| 12 | 007244 | 安信核心竞争力混合C | 13,547,710.00 | 1,714,900.00 | 5.09 |
| 13 | 007243 | 安信核心竞争力混合A | 13,547,710.00 | 1,714,900.00 | 5.09 |
| 14 | 161035 | 富国中证医药主题指数增强(LOF) | 13,238,227.50 | 1,675,725.00 | 2.59 |
| 15 | 512120 | 华安中证细分医药ETF | 11,545,518.20 | 1,461,458.00 | 2.93 |
| 16 | 005587 | 安信比较优势混合 | 7,023,100.00 | 889,000.00 | 4.90 |
| 17 | 165519 | 信诚中证800医药指数分级 | 6,496,920.50 | 822,395.00 | 2.85 |
| 18 | 163118 | 申万菱信中证申万医药生物指数分级 | 4,463,500.00 | 565,000.00 | 1.72 |
| 19 | 162212 | 泰达宏利红利先锋混合 | 2,748,410.00 | 347,900.00 | 4.39 |
| 20 | 008552 | 东财医药指数发起C | 2,415,030.00 | 305,700.00 | 1.92 |
| 21 | 008551 | 东财医药指数发起A | 2,415,030.00 | 305,700.00 | 1.92 |
| 22 | 010366 | 鹏华中证医药指数(LOF)C | 2,347,153.20 | 297,108.00 | 1.90 |
| 23 | 160635 | 鹏华中证医药指数(LOF)A | 2,347,153.20 | 297,108.00 | 1.90 |
| 24 | 002978 | 广发医药卫生联接C | 1,119,430.00 | 141,700.00 | 0.05 |
| 25 | 001180 | 广发医药卫生联接A | 1,119,430.00 | 141,700.00 | 0.05 |
| 26 | 004742 | 易方达深证100ETF联接C | 11,060.00 | 1,400.00 | 0.00 |
| 27 | 110019 | 易方达深证100ETF联接A | 11,060.00 | 1,400.00 | 0.00 |
